Clinical Labelling of Drug Products for Clinical Trials
As drug products progress through clinical trials, they require accurate and compliant labels for open-label and blinded clinical studies.
Clinical labels act as an essential reference point, communicating key information to clinicians and patients alike on everything from dosage level and storage conditions to batch details and expiry date.
For early-phase clinical products, there is often little or no time to hire a separate labeling company to provide an accurate label or the simple blinding of active and placebo drug products. At Aptar Boonton, we’ve developed procedures for open and blinded labeling of clinical supplies. We keep these processes in-house to accelerate the process so your clinical study can start sooner. We can shave months off your development program by providing properly labeled clinical supplies directly from our facility.
Nanopharm cGMP Analytical Release and Stability Testing Solutions
Nanopharm’s specialized clinical development services prepare your latest OINDP product for the clinic. We can engage and manage qualified CMO partner organizations to efficiently produce your early phase cGMP clinical trial materials (CTMs) so you don’t need to seek manufacturers on your own and potentially find yourself in long queues. Our cGMP laboratories can provide stage appropriate analytical method validations and testing services for both CTM release and stability programs so you can advance your OINDPs faster and with confidence.
